Brief introduction of Zheng Jiasheng

Currently, he is the director of minimally invasive interventional center for hepatobiliary tumors in Beijing You 'an Hospital, the head of interventional group for hepatopathy in hepatology department, the deputy head of tumor ablation group of Wu Jieping Medical Foundation, and the director of Beijing Anti-Cancer Association. He used to be the editorial board of Digestion of Chinese in the World, Interventional Radiology in China, Interventional Imaging and Treatment in China and Interventional Radiology. Obtained the first key fund support project, and participated in the 11th Five-Year Plan project of Clinical Collaboration Group for Liver Cancer and the international cooperation project of radiofrequency ablation treatment for liver cancer. He has been engaged in liver disease intervention for 25 years and has rich experience in minimally invasive interventional surgery.

Zheng Jiasheng's "Diagnosis and treatment of space-occupying lesions in sphenoid sinus and pituitary region by transnasal aspiration biopsy under the guidance of interventional radiology" won the second prize of scientific and technological progress of the Health Bureau; The CD-ROM of Interventional Therapy edited by Zheng Jiasheng was published by China Science and Technology Audio-visual Publishing House. Chinese Journal of Radiology and other magazines have published ct-guided percutaneous injection of absolute alcohol for thyroid adenoma, CT-guided dual interventional therapy for liver cancer, analysis of curative effect of hepatic arterial chemoembolization combined with CT-guided radiofrequency ablation for liver cancer, analysis of complications of radiofrequency treatment for liver cancer, emergency arterial embolization for spontaneous rupture and bleeding of liver cancer, bronchial arterial infusion chemoembolization and CT-guided injection of absolute alcohol for ultra-early selective arterial thrombolysis for lung cancer and ischemic stroke.

Because of his outstanding achievements in interventional therapy, 1993 was rated as an advanced worker in Beijing and awarded the title of "model of patriotic meritorious service in Beijing". 65438-0995 CCTV news broadcast reported the curative effect of director Zheng Jiasheng's double interventional therapy for liver cancer, and the major media also reported it. 200 1 CCTV's "Road to Health" gave a 50-minute on-the-spot report on the emergency interventional treatment conducted by Director Zheng Jiasheng. It has formed a unique technology of applying advanced equipment, precise guidance, comprehensive minimally invasive targeted surgery to treat hepatobiliary diseases and minimally invasive targeted surgery to remove tumors. The humanized treatment concept of pattern of systems engineering with whole-course treatment and follow-up guidance greatly improves the success rate of patients' treatment and minimally invasive targeted surgery to remove tumors. The longest survival time of patients with liver cancer reached 15 years.